SANUWAVE Health, Inc. Finance Lease, Right-of-Use Asset, Amortization
SANUWAVE Health, Inc. (SNWV) reported Finance Lease, Right-of-Use Asset, Amortization of $217.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2022-05-13
- SANUWAVE Health, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-12-31 was $58.00K.
- SANUWAVE Health, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-09-30 was $53.00K.
- SANUWAVE Health, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-06-30 was $53.00K.
- SANUWAVE Health, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-03-31 was $53.00K.
- SANUWAVE Health, Inc. finance lease, right-of-use asset, amortization for fiscal 2021 was $217.00K, a 130.85% increase from fiscal 2020.
- SANUWAVE Health, Inc. finance lease, right-of-use asset, amortization for fiscal 2020 was $94.00K, a 180.82% increase from fiscal 2019.
- SANUWAVE Health, Inc. finance lease, right-of-use asset, amortization for fiscal 2019 was $33.47K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month | Finance Lease, Right-of-Use Asset, Amortization 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-13 | $111.00K derived: sum of 2 quarters · filed 2022-05-13 | $164.00K derived: sum of 3 quarters · filed 2022-05-13 | $217.00K 10-K · filed 2022-05-13 | |
| 2021-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-28 | $106.00K derived: sum of 2 quarters · filed 2022-02-28 | $159.00K 10-Q · filed 2022-02-28 | $159.00K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2021-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-14 | $106.00K 10-Q · filed 2022-01-14 | $106.00K derived: sum of 3 quarters · filed 2022-05-13 | $106.00K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2021-03-31 | $53.00K 10-Q · filed 2021-12-13 | $53.00K derived: sum of 2 quarters · filed 2022-05-13 | $53.00K derived: sum of 3 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-05-13 | $94.00K 10-K · filed 2022-05-13 | $200.78K 10-K · filed 2021-10-21 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-28 | $94.00K 10-Q · filed 2022-02-28 | |||
| 2020-06-30 | $94.00K 10-Q · filed 2022-01-14 | ||||
| 2019-12-31 | $33.47K 10-K · filed 2021-10-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |